Literature DB >> 17437663

The utility of nutraceuticals in the treatment of osteoarthritis.

Tracy M Frech1, Daniel O Clegg.   

Abstract

Osteoarthritis (OA) treatment is limited by the inability of prescribed medications to alter disease outcome. As a result, patients with OA often take food substances called nutraceuticals in an attempt to affect the structural changes that occur within a degenerating joint. The role of nutraceuticals in OA management can be defined only by an evidence-based approach to support their use. This paper reviews the clinical trials studying glucosamine, chondroitin sulfate, vitamin C, vitamin E, and avocado-soybean unsaponifiables. It highlights the need for additional randomized, placebo-controlled trials to further define the utility of nutraceuticals in OA treatment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17437663     DOI: 10.1007/s11926-007-0018-x

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  42 in total

Review 1.  EULAR Recommendations 2003: an evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT).

Authors:  K M Jordan; N K Arden; M Doherty; B Bannwarth; J W J Bijlsma; P Dieppe; K Gunther; H Hauselmann; G Herrero-Beaumont; P Kaklamanis; S Lohmander; B Leeb; M Lequesne; B Mazieres; E Martin-Mola; K Pavelka; A Pendleton; L Punzi; U Serni; B Swoboda; G Verbruggen; I Zimmerman-Gorska; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

2.  Indexes of severity for osteoarthritis of the hip and knee. Validation--value in comparison with other assessment tests.

Authors:  M G Lequesne; C Mery; M Samson; P Gerard
Journal:  Scand J Rheumatol Suppl       Date:  1987

3.  Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study.

Authors:  Karel Pavelká; Jindriska Gatterová; Marta Olejarová; Stanislav Machacek; Giampaolo Giacovelli; Lucio C Rovati
Journal:  Arch Intern Med       Date:  2002-10-14

4.  Glucosamine sulfate in osteoarthritis of the knee.

Authors:  W Noack; M Fischer; K K Förster; L C Rovati; I Setnikar
Journal:  Osteoarthritis Cartilage       Date:  1994-03       Impact factor: 6.576

5.  Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial.

Authors:  J Y Reginster; R Deroisy; L C Rovati; R L Lee; E Lejeune; O Bruyere; G Giacovelli; Y Henrotin; J E Dacre; C Gossett
Journal:  Lancet       Date:  2001-01-27       Impact factor: 79.321

6.  Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.

Authors:  P Morreale; R Manopulo; M Galati; L Boccanera; G Saponati; L Bocchi
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

Review 7.  Role of eicosanoids in structural degradation in osteoarthritis.

Authors:  Stefan Laufer
Journal:  Curr Opin Rheumatol       Date:  2003-09       Impact factor: 5.006

8.  Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.

Authors:  Daniel O Clegg; Domenic J Reda; Crystal L Harris; Marguerite A Klein; James R O'Dell; Michele M Hooper; John D Bradley; Clifton O Bingham; Michael H Weisman; Christopher G Jackson; Nancy E Lane; John J Cush; Larry W Moreland; H Ralph Schumacher; Chester V Oddis; Frederick Wolfe; Jerry A Molitor; David E Yocum; Thomas J Schnitzer; Daniel E Furst; Allen D Sawitzke; Helen Shi; Kenneth D Brandt; Roland W Moskowitz; H James Williams
Journal:  N Engl J Med       Date:  2006-02-23       Impact factor: 91.245

9.  Double-blind clinical evaluation of oral glucosamine sulphate in the basic treatment of osteoarthrosis.

Authors:  J M Pujalte; E P Llavore; F R Ylescupidez
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

10.  Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo.

Authors:  P Bourgeois; G Chales; J Dehais; B Delcambre; J L Kuntz; S Rozenberg
Journal:  Osteoarthritis Cartilage       Date:  1998-05       Impact factor: 6.576

View more
  4 in total

1.  A combined phase I and II open label study on the effects of a seaweed extract nutrient complex on osteoarthritis.

Authors:  Stephen P Myers; Joan O'Connor; J Helen Fitton; Lyndon Brooks; Margaret Rolfe; Paul Connellan; Hans Wohlmuth; Phil A Cheras; Carol Morris
Journal:  Biologics       Date:  2010-03-24

2.  Effects of diet type and supplementation of glucosamine, chondroitin, and MSM on body composition, functional status, and markers of health in women with knee osteoarthritis initiating a resistance-based exercise and weight loss program.

Authors:  Teresa Magrans-Courtney; Colin Wilborn; Christopher Rasmussen; Maria Ferreira; Lori Greenwood; Bill Campbell; Chad M Kerksick; Erica Nassar; Rui Li; Mike Iosia; Matt Cooke; Kristin Dugan; Darryn Willoughby; LuAnn Soliah; Richard B Kreider
Journal:  J Int Soc Sports Nutr       Date:  2011-06-20       Impact factor: 5.150

Review 3.  Food for Special Medical Purposes and Nutraceuticals for Pain: A Narrative Review.

Authors:  Roberto Casale; Zaira Symeonidou; Sofia Ferfeli; Fabrizio Micheli; Paolo Scarsella; Antonella Paladini
Journal:  Pain Ther       Date:  2021-02-16

4.  Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial.

Authors:  Douglas S Kalman; Maria Heimer; Anita Valdeon; Howard Schwartz; Eric Sheldon
Journal:  Nutr J       Date:  2008-01-21       Impact factor: 3.271

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.